Connect with us

Health

COVID-19 and T cell response after vaccination

 


Antibodies induced after coronavirus disease 2019 (COVID-19) vaccination or SARS-CoV-2 infection have the ability to cross-neutralize the variant of concern (VOC). It is declining. However, antibodies are not the only mediator of immunity.

New research published in the journal Immunology Frontier Investigate the cell-mediated immunity of BNT162b2COVID-19 mRNA vaccinated healthcare professionals and COVID-19 patients.

Study: Long-lasting T cell response in BNT162b2 COVID-19 mRNA vaccine and COVID-19 convalescent patients. Image Credit: Corona Borealis Studio / Shutterstockstudy: Long-lasting T cell response in BNT162b2 COVID-19 mRNA vaccine and COVID-19 convalescent patients.. Image Credit: Corona Borealis Studio / Shutterstock

Cell-mediated immunity

T cells A cell-based immune mediator. They play important roles in immune protection, recovery from acute infections, and long-term immunological memory.

The antigen-Presentation cells (APCs) present some short peptides of viral proteins to T cells. The T cell response is stimulated by these different short peptides. Therefore, T cell responses are not sensitive to viral protein mutations such as antibody responses.

CD8 + cytotoxic T lymphocytes (CTLs) identify and destroy virus-infected cells. CD4 + T helper (Th) cells regulate and enhance CTL response. They also stimulate antibody production by B cells.

Previous studies have shown that SARS-CoV-2 infection stimulates strong memory CD4 + and CD8 + T cell responses. This cell-mediated immunity may provide long-term protection against reinfection.

Evaluation of cell-mediated immunity

This study analyzes the lifespan of SARS-CoV-2 spike-specific antibodies and cell-mediated immunity in BNT162b2 vaccinated healthcare professionals and COVID-19 patients.

The study included 23 fully vaccinated medical personnel (two doses of BNT162b2 vaccine), 15 COVID-19 patients, and previously SARS-CoV-2 infection or COVID-19 vaccination. Included 13 individuals who did not receive it. Blood samples were collected from vaccinated individuals 6 weeks, 3 months, and 6 months after the first vaccination. Patients with convalescent COVID-19 18-45 days (33 days on average) after SARS-CoV-2 infection.

Peripheral blood mononuclear cells (PBMCs) were isolated from the blood and activated with peptides throughout the SARS-CoV-2 peplomer. T cell subtypes within the PBMC population were characterized using flow cytometry.

Expression of various cytokines was measured using RT-qPCR. In addition, Luminex was used to detect levels of cytokines and other molecules secreted by cells. Anti-SARS-CoV-2 antibody was measured using the enzyme immunoassay (EIA). The activation-inducing marker (AIM) assay was optimized prior to analyzing the sample.

PBMC was stimulated with the wild-type SARS-CoV-2 Wuhan virus spike peptide pool. 48 hours of stimulation and measurements of IFN-γ and IL-2 mRNA levels were selected for all analyses. Tetanus toxoid was used as a positive control. Both IFN-γ and IL-2 are Th1 cytokines.

T cell response

SARS-CoV-2 spike-specific CD4 + cellular responses were detected in all COVID-19 patients and vaccinated individuals 6 weeks, 3 months, and 6 months after the first vaccination.

A CD8 + cellular response was detected 6 weeks after the first dose in 80% of COVID-19 patients and 70% of vaccinated individuals. 67% of vaccinated individuals 3 months after the first dose. In 53% of vaccinated individuals, 6 months after the first dose. These T cell responses were similar in COVID-19 patients and vaccinated individuals.

The T cell response to VOCs was assessed by stimulating PBMCs with a peptide pool from. Spike protein Of alpha, beta, gamma, and delta variants. A CD4 + cellular response to all VOCs tested was detected in ≥71% of vaccinated individuals and ≥75% of COVID-19 patients.

CD8 + T cell responses to all VOCs tested were detected in ≥50% of vaccinated individuals and ≥75% of COVID-19 patients. However, a significant difference was observed between the wild-type and gamma mutants 6 weeks after vaccination and the wild-type and beta mutants 6 months after vaccination.

Patients with COVID-19 had a stronger response to CD4 + and CD8 + than those vaccinated. After 6 months, there was no decrease in cell-mediated immunity to VOCs.

Expression of IFN-γ and IL-2 mRNA was detected in 93% and 100% of vaccinated individuals after stimulation with wild-type and delta mutant spike peptide pools. mRNA levels were higher compared to PBMC mRNA levels collected from unvaccinated and uninfected individuals. Expression of IFN-γ and IL-2 mRNA was similar between COVID-19 patients and vaccinated individuals.

Correlation between humoral immunity and cell-mediated immunity after BNT162b2 vaccination n = 23 and SARS-CoV-2 infection.  (A) Anti-SARS-CoV-2 S1-specific IgG, S1-total Ig, and N-protein-specific IgG antibody responses were measured from samples collected 6 weeks, 3 months, and 6 months after vaccination. ..  After n = 23 or 1-month PCR confirms SARS-CoV-2 infection (n = 15). Serum antibody levels in vaccinated and infected individuals were compared to negative controls (n = 13) who had not been vaccinated with COVID-19 or had previously been infected with SARS-CoV-2. The bar represents the geometric mean titer. The cutoff value for positive test results is shown by the dotted line. Statistical analysis was performed with the Mann-Whitney U test to compare a 6-week vaccinated sample with a COVID-19 patient sample.  **** p<0.0001。  (B、C)抗SARS-CoV-2 S1 IgG抗体レベルとSARS-CoV-2(wt)スパイク特異的CD4+およびCD8+ T細胞応答との相関(B)ワクチン接種医療従事者(サンプルは6週間、3か月で収集) 、およびワクチン接種後6か月、

Correlation between humoral immunity and cell-mediated immunity after BNT162b2 vaccination n = 23 and SARS-CoV-2 infection. (A) Anti-SARS-CoV-2 S1-specific IgG, S1-total Ig, and N-protein-specific IgG antibody responses were measured from samples collected 6 weeks, 3 months, and 6 months after vaccination. .. After n = 23 or 1-month PCR confirms SARS-CoV-2 infection (n = 15). Serum antibody levels in vaccinated and infected individuals were compared to negative controls (n = 13) who had not been vaccinated with COVID-19 or had previously been infected with SARS-CoV-2. The bar represents the geometric mean titer. The cutoff value for positive test results is shown by the dotted line. Statistical analysis was performed with the Mann-Whitney U test to compare a 6-week vaccinated sample with a COVID-19 patient sample. **** p <0.0001. (B, C) Correlation between anti-SARS-CoV-2 S1 IgG antibody levels and SARS-CoV-2 (wt) spike-specific CD4 + and CD8 + T cell responses (B) Vaccinated medical personnel (sample 6 weeks, sample) Collected at 3 months), and 6 months after vaccination, n = 52) and (C) COVID-19 patients (sample collected 1 month after onset of symptoms, n = 15). The correlation is analyzed by Spearman's correlation and Spearman's r is shown in the figure.

After stimulating PBMC from individuals vaccinated with wild-type and delta mutant spike peptide pools, IFN-γ and IL-2 protein levels were significantly increased. Levels of IFN-γ and IL-2 were higher in vaccinated individuals and in COVID-19 patients than in unvaccinated, uninfected individuals. IFN-γ and IL-2 levels did not decrease 6 months after vaccination. In addition, stimulation with wild-type or delta mutant peptide pools produced comparable IFN-γ and IL-2 levels.

There was a high correlation between T cell activation and the production of IFN-γ and IL-2 cytokines.

All vaccinated individuals produced spike-specific anti-SARS-CoV-2 antibodies 6 weeks after the first vaccination. Antibody levels were higher than those in hospitalized COVID-19 patients. In vaccinated individuals, antibody levels gradually declined.

Levels of anti-SARS-CoV-2 antibody in vaccinated individuals did not correlate with CD4 + or CD8 + T cell responses. However, in COVID-19 patients, spike-specific anti-SARS-CoV-2 antibodies increased with increased CD4 + and CD8 + T cell responses.

Research limits

In this study, PBMCs were cryopreserved until analysis. This reduces cell viability and can result in the loss of some memory cells in the process. The number of participants evaluated in this study was relatively small. Only individuals vaccinated with BNT162b2 were studied. This study does not include vaccinated individuals over the age of 60. The AIM protocol did not test longer incubation times. Instead of 9-10 mer peptides, a longer 15 mer peptide pool was used for stimulation. This may underestimate SARS-CoV-2 specific CD8 + cells.

Conclusion

This study found that even if SARS-CoV-2 peplomer-specific antibodies declined over time after COVID-19 vaccination or spontaneous infection, cellular immunity was significantly retained and insensitive to viral peplomer mutations. Is shown.

Sources

1/ https://Google.com/

2/ https://www.news-medical.net/news/20220512/T-cell-responses-after-COVID-19-and-vaccinations.aspx

The mention sources can contact us to remove/changing this article

What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos

ExBUlletin

to request, modification Contact us at Here or [email protected]